San Diego 3-D bioprinting company Organovo Holdings Inc. has appointed Greg Lucier as a corporate advisor. In the role Lucier will advise Chief Executive Officer Keith Murphy and the executive management team on various corporate issues.

Lucier was formerly chairman and CEO of Life Technologies Corp., a global life sciences company acquired by Thermo Fisher Scientific for $15.6 billion in 2014. While at Life Technologies, he led the company from a small startup known as Invitrogen in 2003 to being a world-leading biotechnology firm renamed Life Technologies with 50,000 products, 12,000 employees and nearly $4 billion in sales.

“I’m pleased to be asked to help the executive management of Organovo deliver on the promise of three dimensional bioprinting,” Lucier said. “As I have learned more about Organovo’s team and technology, it’s clear there is a compelling opportunity to advance their early scientific performance into strong commercial wins. I look forward to using my leadership experience, strategic thinking in life sciences industry and track record bringing biomedical commercial solutions to the market to help guide the company in its next phase.”

Organovo designs and creates functional, three dimensional human tissues for medical research and therapeutic applications. The company is working with pharmaceutical and academic partners to develop human biological disease models in three dimensions.